Recently, a 47-year-old Turkish woman, diagnosed with aggressive diffuse large B-cell lymphoma, made a strong recovery after receiving precision treatment at the First Affiliated Hospital of CQMU. Her experience is a reflection of the high-level international medical services in China.
The patient, named Zeynep (pseudonym), has been living and working in Chongqing for an extended period. In late 2024, she visited the First Affiliated Hospital due to physical discomfort and was diagnosed with aggressive diffuse large B-cell lymphoma, with extensive lymph node involvement throughout her body, indicating a severe condition. In early January 2025, her condition worsened and she developed acute respiratory failure. At first, she and her family considered returning to Turkey for treatment. However, through a remote consultation, Turkish specialists highly praised the preliminary treatment plan proposed by the doctors at the First Affiliated Hospital. She then immediately decided to stay in China to continue her treatment.
The hospital’s Department of Hematology initiated a multidisciplinary team (MDT) consultation. Experts from hematology, pathology, the Clinical Molecular Center, intensive care medicine, endocrinology, and respiratory and critical care medicine jointly discussed the patient’s condition and developed a personalized treatment plan. “We adopted an individualized first-line regimen based on international standard—Pola R-CHP—which pairs a targeted antibody with chemotherapy,” said Zhang Hongbin, chief physician of the Department of Hematology. “This approach can improve the patient’s survival rate from 60% to 80%”.
Within just seven days of treatment, Zeynep’s tumor volume had already shrunk by 40%, and her symptoms improved significantly. Over a period of more than six months, she underwent eight cycles of treatment, and her condition has now been fully controlled. At present, she continues to attend regular follow-up appointments with her doctors to closely monitor her health. Zeynep and her family also invited Zhang Hongbin and the medical team to enjoy Turkish cuisine as a gesture of their sincere gratitude.
(Translated by AI)
